- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 29.06M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 25.6M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 15.09M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$432.97K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$689.62K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$11.45M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$11.22M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $8.53M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $8.31M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $13.95M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $13.67M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.02M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $814.47K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.32M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.15M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.06 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $775.45K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $886.08K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $352.33K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $161.92K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$831.23K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$841.41K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$956K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$937.95K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $25.18K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $0 |
| Revenue | Q1 2026 · Mar 31, 2026 | $214.54K |
| Revenue | Q1 2026 · Mar 31, 2025 | $134.9K |